Bide Pharmatech Co

Bide Pharmatech Co EBIT per Employee

The EBIT per Employee of Bide Pharmatech Co (688073.SS) as of Oct 15, 2026 is 391,654.26 CNY. In the previous year, EBIT per Employee was 257,091.57 CNY — a change of 52.34% (higher).

EBIT per Employee

391,654.26CNY

YoY

52.34%

Last updated:

EBIT per Employee of Bide Pharmatech Co is 2025 391,654.26 CNY. EBIT per Employee of Bide Pharmatech Co was 2024 257,091.57 CNY. It decreases by 52.34% higher compared to the previous year.

The Bide Pharmatech Co EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
9,936.63 CNY
Jan 1, 2020
148,217.88 CNY
Jan 1, 2021
201,064.01 CNY
Jan 1, 2022
269,367.78 CNY
Jan 1, 2023
208,699.06 CNY
Jan 1, 2024
257,091.57 CNY
Jan 1, 2025
391,654.26 CNY
The Bide Pharmatech Co EBIT per Employee history
YEAREBIT per EmployeeYoY
391,654.26CNY+52.34%
257,091.57CNY+23.19%
208,699.06CNY-22.52%
269,367.78CNY+33.97%
201,064.01CNY+35.65%
148,217.88CNY+1,391.63%
9,936.63CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bide Pharmatech Co Stock analysis

What does Bide Pharmatech Co do? Bide Pharmatech Co Ltd is a pharmaceutical company headquartered in Shanghai, China, operating within the Health Care sector. The company focuses on the research, development, design, production, and sales of drug molecular building blocks, which are essential components in pharmaceutical manufacturing. Its main products include pharmaceutical molecular building blocks and scientific reagents, utilized in various stages of drug development such as target discovery, compound screening, and synthesis optimization. Bide Pharmatech employs 617 full-time staff and completed its initial public offering (IPO) on October 11, 2022. The company serves markets across the Asia Pacific region, India, Europe, and the United States. Its website is https://www.bidepharmatech.com/. The firm's operations are centered on providing specialized chemical solutions for the pharmaceutical industry, supporting the development of new drugs and therapeutic compounds. Bide Pharmatech does not disclose specific details about its founding year, key executives, or acquisition history. Financial figures beyond the employee count and IPO date are not provided in the available information. The company operates as a publicly traded entity under the ticker symbol 688073.SS and ISIN CNE100005NV3. It maintains a presence in multiple global markets, emphasizing its role in the pharmaceutical supply chain as a supplier of critical molecular components. Bide Pharmatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bide Pharmatech Co stock

EBIT per Employee of Bide Pharmatech Co is 391,654.26 CNY in 2025.

EBIT per Employee of Bide Pharmatech Co changed from 257,091.57 CNY to 391,654.26 CNY, representing a 52.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Bide Pharmatech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Bide Pharmatech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Bide Pharmatech Co

All Key Metrics — Bide Pharmatech Co